Publications by authors named "Laura Luberto"

Claim this Profile
A
A Novel Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier.
Loredana Vesci, Grazia Tundo, Sara Soldi, Serena Galletti, Daniela Stoppoloni, Laura Luberto

Nutrients· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.
Emanuela D'Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Laura Luberto

Antibodies (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.
Ferdinando M Milazzo, Antonio Chaves-Sanjuan, Olga Minenkova, Daniela Santapaola, Anna M Anastasi, Laura Luberto

Mol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.
Olga Minenkova, Daniela Santapaola, Ferdinando Maria Milazzo, Anna Maria Anastasi, Gianfranco Battistuzzi, Laura Luberto

Mol Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
Antonella Conforti, Emanuele Marra, Fabio Palombo, Giuseppe Roscilli, Micol Ravà, Laura Luberto

Mol Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections.
Laura Luberto, Bruna Neroni, Orietta Gandini, Ersilia Vita Fiscarelli, Giovanni Salvatori

Front Microbiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity and Local Tolerance of COVID- Vax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation.
Yuval Ramot, Gianfranco Caselli, Luigi Aurisicchio, Isabella Andreini, Emanuele Marra, Laura Luberto

Toxicol Pathol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Giovanni Salvatori, Laura Luberto, Mariano Maffei, Luigi Aurisicchio, Giuseppe Roscilli

J Transl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.
Luigi Aurisicchio, Erika Salvatori, Lucia Lione, Silvio Bandini, Matteo Pallocca, Laura Luberto

J Exp Clin Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
Cédric Poyet, Linto Thomas, Tobias M Benoit, David Aquino Delmo, Laura Luberto

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.
Loredana Vesci, Ferdinando Maria Milazzo, Anna Maria Anastasi, Fiorella Petronzelli, Caterina Chiapparino, Laura Luberto

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen.
Luigi Aurisicchio, Giuseppe Roscilli, Emanuele Marra, Laura Luberto, Rita Mancini

Hum Gene Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer.
Alessia Noto, Claudia De Vitis, Giuseppe Roscilli, Luigi Fattore, Debora Malpicci, Laura Luberto

Oncotarget· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.
Alessandra Gavazza, George Lubas, Arthur Fridman, Daniela Peruzzi, Joseph A Impellizeri, Laura Luberto

Hum Gene Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors.
Luigi Aurisicchio, Emanuele Marra, Laura Luberto, Fabrizio Carlomosti, Claudia De Vitis

J Cell Physiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder.
Camillo Palmieri, Cristina Falcone, Enrico Iaccino, Franca Maria Tuccillo, Marco Gaspari, Laura Luberto

Blood· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes.
Luca Gallelli, Manuela Colosimo, Grazia A Tolotta, Daniella Falcone, Laura Luberto

Eur J Clin Pharmacol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis